Document is current
Any future updates will be listed below
-
Authors
Salmón-Gómez, Laura https://orcid.org/0000-0002-7223-512X
Catalán, Victoria https://orcid.org/0000-0002-7513-7509
Ramírez, Beatriz https://orcid.org/0000-0003-3381-7220
Aguas-Ayesa, Maite https://orcid.org/0000-0003-1156-4904
Rodríguez, Amaia https://orcid.org/0000-0002-2180-461X
Becerril, Sara https://orcid.org/0000-0002-3441-1970
Baixauli, Jorge
Gutiérrez-Medina, Sonsoles
Mugueta, Carmen https://orcid.org/0000-0003-2800-4735
Colina, Inmaculada https://orcid.org/0000-0003-2454-9455
Perdomo, Carolina M. https://orcid.org/0000-0002-5748-0581
Silva, Camilo https://orcid.org/0000-0002-3466-1291
Escalada, Javier https://orcid.org/0000-0001-5877-9465
Frühbeck, Gema https://orcid.org/0000-0002-8305-7154
Gómez-Ambrosi, Javier https://orcid.org/0000-0001-5601-1604
-
Funding
Funding for this research was provided by:
Universidad de Navarra
- License Information
-
More Information
Article History
Received: 19 May 2025
Accepted: 1 August 2025
First Online: 19 August 2025
Declarations
:
: GF declares payment of honoraria for lectures from Novo Nordisk as a member of the OPEN Spain Initiative as well as payment of honoraria for attendance at advisory boards from Lilly, Novo Nordisk, Regeneron, and AstraZeneca and declares no competing interest, financial or nonfinancial, related to this work. The other authors declared no conflict of interest.
